Improving clinical trial diversity
The American Heart Association has provided funding to two Stanford Medicine professors to develop ways to diversify enrollment in heart disease clinical trials.
Gummy phlegm and COVID-19
Levels of a stringy, spongy substance soar in the sputum of COVID-19 patients requiring intubation, accounting for at least some of their breathing trouble. Development of an off-patent drug may prevent it.
Stanford Medicine provides monkeypox test
Stanford Medicine now provides a test for the monkeypox virus. Rapid identification of infected people will help combat the virus’s spread and facilitate patient care.
COVID vaccine approved for young kids
Children as young as 6 months can now receive the Pfizer BioNTech and Moderna mRNA vaccines.
Immunosuppression-free kidney transplant
Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.
$13 million for cancer research
The funding, from Cancer Grand Challenges, will help the researchers address difficult problems in cancer prevention, treatment-resistant cancers and therapies for pediatric solid tumors.
‘Anti-hunger’ molecule discovered
Stanford Medicine researchers and their collaborators have identified a molecule that staves off hunger post-exercise.
Jeffrey Glenn receives $69 million grant
Stanford Medicine’s SyneRx will develop drugs to fight viral pathogens with high pandemic potential, including the one that causes COVID-19.
1,000+genes linked to severe COVID-19
Using machine learning, researchers from Stanford Medicine and their collaborators found specific genetic signals in people who develop severe coronavirus infection.
COVID-19 brain fog similar to chemo brain
Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.